Lung transplantation for patients with severe COVID-19
Lung transplantation can potentially be a life-saving treatment for patients with nonresolving
COVID-19–associated respiratory failure. Concerns limiting lung transplantation include …
COVID-19–associated respiratory failure. Concerns limiting lung transplantation include …
[HTML][HTML] Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries
A Bharat, TN Machuca, M Querrey… - The lancet respiratory …, 2021 - thelancet.com
Background Lung transplantation is a life-saving treatment for patients with end-stage lung
disease; however, it is infrequently considered for patients with acute respiratory distress …
disease; however, it is infrequently considered for patients with acute respiratory distress …
Clinical characteristics and outcomes of patients with COVID-19–associated acute respiratory distress syndrome who underwent lung transplant
C Kurihara, A Manerikar, M Querrey, C Felicelli… - Jama, 2022 - jamanetwork.com
Importance Lung transplantation is a potentially lifesaving treatment for patients who are
critically ill due to COVID-19–associated acute respiratory distress syndrome (ARDS), but …
critically ill due to COVID-19–associated acute respiratory distress syndrome (ARDS), but …
Feasibility of venovenous extracorporeal membrane oxygenation without systemic anticoagulation
C Kurihara, JM Walter, A Karim, S Thakkar… - The Annals of thoracic …, 2020 - Elsevier
Background Venovenous extracorporeal membrane oxygenation (ECMO) is increasingly
being used for acute respiratory distress syndrome and as a bridge to lung transplantation …
being used for acute respiratory distress syndrome and as a bridge to lung transplantation …
Outcomes after extracorporeal membrane oxygenation support in COVID‐19 and non‐COVID‐19 patients
C Kurihara, A Manerikar, CA Gao, S Watanabe… - Artificial …, 2022 - Wiley Online Library
Background Veno‐venous extracorporeal membrane oxygenation (V‐V ECMO) support is
increasingly used in the management of COVID‐19‐related acute respiratory distress …
increasingly used in the management of COVID‐19‐related acute respiratory distress …
[HTML][HTML] Crosstalk between nonclassical monocytes and alveolar macrophages mediates transplant ischemia-reperfusion injury through classical monocyte …
C Kurihara, E Lecuona, Q Wu, W Yang… - JCI insight, 2021 - ncbi.nlm.nih.gov
Primary graft dysfunction (PGD) is the predominant cause of early graft loss following lung
transplantation. We recently demonstrated that donor pulmonary intravascular nonclassical …
transplantation. We recently demonstrated that donor pulmonary intravascular nonclassical …
Lung transplantation in coronavirus-19 patients: What we have learned so far
E Cerier, K Lung, C Kurihara… - Clinics in Chest …, 2023 - chestmed.theclinics.com
The novel coronavirus-19 (COVID-19) has infected more than 490 million people since the
start of the pandemic in March 2020, causing over 6.1 million deaths. 1 Although some …
start of the pandemic in March 2020, causing over 6.1 million deaths. 1 Although some …
Impact of Screening and Treatment of Ureaplasma species on Hyperammonemia Syndrome in Lung Transplant Recipients: A Single Center Experience
SC Roberts, A Bharat, C Kurihara… - Clinical Infectious …, 2021 - academic.oup.com
Abstract Background Infection with Ureaplasma species (spp) has been linked to fatal
hyperammonemia syndrome (HS) in lung transplant recipients. We sought to characterize …
hyperammonemia syndrome (HS) in lung transplant recipients. We sought to characterize …
Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) scoring system to predict outcomes in patients who undergo left ventricular …
A Critsinelis, C Kurihara, N Volkovicher… - The Annals of Thoracic …, 2018 - Elsevier
Background The use of continuous-flow left ventricular assist devices (CF-LVADs) to treat
advanced heart failure is increasing. Although risk scores, such as Model for End-Stage …
advanced heart failure is increasing. Although risk scores, such as Model for End-Stage …
Extracorporeal membrane oxygenation can successfully support patients with severe acute respiratory distress syndrome in lieu of mechanical ventilation
C Kurihara, JM Walter, BD Singer, H Cajigas… - Critical Care …, 2018 - journals.lww.com
Objectives: Extracorporeal membrane oxygenation is increasingly used in the management
of severe acute respiratory distress syndrome. With extracorporeal membrane oxygenation …
of severe acute respiratory distress syndrome. With extracorporeal membrane oxygenation …